ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GLMD Galmed Pharmaceuticals Ltd

0.3874
0.0023 (0.60%)
May 03 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -7.49M-6.09M-3.73M-5.38M-2.45M-2M-1.87M-1.47M
Pre Tax Income -7.45M-6.14M-3.73M-5.35M-2.64M-1.83M-1.59M-1.47M
Net Income -7.45M-6.14M-3.73M-5.35M-2.64M-1.83M-1.59M-1.47M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -7.57M-6.09M-3.73M-5.38M-2.98M-2M-1.87M-1.47M
EBITDA -7.48M-6.08M-3.72M-5.37M-2.44M-1.99M-1.86M-1.46M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 467k1.09M2.04M00000
Operating Income -16.88M-12.36M-10.72M-22.38M-30.21M-32.88M-17.65M-7.49M
Pre Tax Income -16.85M-12.3M-9.78M-20.46M-28.77M-32.47M-17.87M-6.91M
Net Income -16.95M-12.3M-9.86M-20.46M-28.77M-32.47M-17.87M-6.91M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.395-0.852-0.469-0.968-1.349-1.294-0.709-1.37
EBIT -16.85M-12.3M-10.76M-22.38M-30.21M-32.96M-18.18M-7.51M
EBITDA -16.71M-12.13M-10.33M-22.34M-30.17M-32.84M-17.62M-7.46M

Your Recent History

Delayed Upgrade Clock